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Implementation of Evidence-Based Practices In
Opioid Substance Abuse Treatment
Elizabeth V. Keck, LSW
Statement of Purpose
The purpose of this capstone project is to begin the implementation
of evidence-based practices for opioid substance abuse population
in the rural community of Owatonna, MN and the surrounding
communities.

David Wright, LICSW
Dr. Annelies Hagemeister, Academic Advisor
Carol Goodemann, Field Liaison
Department of Social Work, Minnesota State University, Mankato
Dual Recovery Program, South Central Human Relations Center
	
  

Detoxification

Literature Review
•2 million adults in the United States are dependent on heroin or non-medically
prescribed prescription opioids (SAMHSA, 2006).
•Opioid dependency has significant costs to society; $2.6 billion in health care
costs annually, $1.4 billion in the criminal justice system; $4.6 billion to workplace
(Journal of Clinical Pain, 2006).
•Opioid dependence is a chronic and severe disorder associated with a
substantial risk of mortality, and other psychiatric morbidity, as well as adverse
social, vocational, familial, and legal consequences (Galanter & Kelber, 2008).
•Analyses show that there is significant variations in the availability of evidencebased practice substance abuse for opioid dependent clients (Doran, 2008).
•Medication-assisted treatment is an evidence-based practice for opioid addiction
(SAMHSA, 2006).
•Medication-assisted treatment (MAT) is the use of agonistic and/or antagonistic
medications such as buprenorphine, suboxone, methadone, or naltrexone in
combination with counseling and recovery support services (SAMHSA TIP 43,
2005).
•Despite research which supports medication-assisted substance abuse
treatment is cost effective (Doran, 2008) and is an evidence-based practice for
treatment for opioid dependence (SAMHSA, 2006) the implementation of these
practices has yet to evolve in some rural communities.

Table 1: Admissions to Substance Abuse
Treatment Programs for Opioid Dependence
has Increased in Minnesota in the Last Ten
Years

Table 2: Admission to Substance Abuse
Treatment Programs for Opioid
Dependence has Increased Throughout
the United States

Substance
Abuse
Treatment

MedicationAssisted
Treatment

Various
Permutations
of the other three

A. Detoxification involves medically supervised withdrawal involving agonist and/or
non-agonist medications. Generally, detoxification is coupled with substance abuse
treatment and/or psychosocial interventions. Relapse rates for detoxification programs
are high.
In a British study with a 28 day hospital
based detoxification program almost 75%
of patients had relapsed at 6 months.

This British study demonstrated how
quickly opioid addicts relapsed after
detoxification program. After 6 weeks
50% of patients relapsed.

Source: Journal of Clinic Pain, 2006

Table 3: Opioid Abusers have increased Health
Costs Compared to Non-opioid Abusers

intended to reduce harmful substance abuse.
• Theories can include the following: 12 Step Facilitation, Cognitive-Behavioral
Therapy, Contingency Management, Community Reinforcement.
• Treatment Modalities include: Inpatient Treatment, Outpatient Treatment, Partial
Hospitalizations.
• Drug free treatment
• Very few studies have reported treatment outcomes for opioid abusers enrolled in
drug-free outpatient treatment.
• We need to continue the evolution and evaluation of all forms of treatment.

•It is an evidence-based practice to treat adults with dual diagnoses of opioid
dependence and a mental illness (SAMHSA, 2011).
•MAT relapse rates are superior to detoxification programs. In a one year study
completed by Kakko, Svanberg, Kreek, and Helly (2003) clients who participated in
Buprenorphine medication-assisted treatment program only 25% had relapsed after
one year. MAT relapse rates are superior to detoxification programs.
•Retention rates in MAT treatment are greater than detoxification programs. Mohan,
Dhawan, Chopan, and Sethi (2006) found 81.5% of clients who participated in MAT
program remained in treatment at 24 weeks.
•MAT is a cost-effective intervention for treating opioid dependence. Doran (2008)
completed a review of 259 articles to determine cost effectiveness of MAT. Doran
found both the use of buprenorphine and methadone to be cost-effective.

Source: Journal of Managed Care Pharmacy, (2005)

1.Identification of evidence-based practices for the treatment of
individuals diagnosed with opioid dependence.
2.Development of training on evidence-based practices for opioid
dependence.
3.Training provided for mental health professionals, case
managers, substance abuse treatment providers, criminal justice
system workers, social services providers, chemical health
assessors, and other community members.
4.Development and implementation of training for Primary Care
Physicians at Mayo Clinic Health Systems–Owatonna Clinic.
5.Meeting with Allina Health–Owatonna Hospital to develop
Emergency Department response to opioid dependency.
6.Identification of key stakeholders who can assist with the
development and implementation of evidence-based
practices
for opioid dependence.
7.Identification of gaps in the service delivery area.
8.Memorandum of Agreement presented for signature to work
towards the implementation of evidence-based practices in
Owatonna Minnesota and the surrounding communities.

B. Substance abuse treatment involves psychological and psychosocial interventions

C. Medication-assisted treatment (MAT) is the use of agonistic and/or antagonistic
medications such as buprenorphine, suboxone, methadone, or naltrexone in
combination with counseling and recovery support services (SAMHSA TIP 43, 2005).
Source: R. Moldenhauer, Minnesota State Opioid Treatment Authority (DAANE)

Project Methodology

Current Modalities of Treatment

Conclusions & Recommendations

Gaps in Service Delivery Include:
1. Physician with prescribing privileges.
2. Screening tools not adequately being used.
3. Clients being referred to detoxification program and not MAT.
4. Clients are not able to receive MAT in their own community.
Recommendations
Key stakeholders work towards the development of implementing
evidence-based practices. Key stakeholders meet on a quarterly
basis to develop workflow plan for the development of MAT
program.
Benefits to Agency
Dual Recovery Program will be able to continue the development of
an MAT program within their agency.
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